Companies: 10,795·Total market cap: $144.5T
Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

ARWRNASDAQHealthcare● Active
$73.09
$-2.07(-2.75%)
Market Cap$10.3B
P/E Ratio
52W High$82.26
52W Low$14.3
Overview

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ARWR · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.14arwr eps ttm · arwr earnings per shareEarnings history
PE Ratio (TTM)arwr pe ratio ttm · arwr price to earningsPE Ratio deep dive
Revenue (TTM)$622.0Marwr revenue ttm · arwr annual revenueFull revenue history
Dividend YieldNo Dividenddoes arwr pay dividends · arwr dividend yieldDividend history
Shares Outstanding133.8Marwr shares outstanding · arwr floatShares outstanding history
Next EarningsAug 6, 2026Est.arwr earnings date · arwr next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$829.4M▲ +23258.15% YoY
202320242025
arrowhead pharmaceuticals, inc. revenue · arwr revenue 2025
FY 2025Net Income-$1.6M▲ +99.73% YoY
202320242025
arrowhead pharmaceuticals, inc. net income · arwr profit 2025
FY 2025EPS$-0.01▲ +99.76% YoY
202320242025
arwr eps · arrowhead pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $622.0MNet Income: -$300.9MEPS: $-2.14View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy20 analystsis arwr a buy · arwr analyst rating
Strong Buy
0
Buy
15
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$73.09Current
$83.56Avg Target14.32% upside
$110.00High
arwr price target · arwr 12 month forecast

Total: 20 · Buy rate: 75.0%

The ARWR analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month price target is $83.56, representing +14.32% upside from the current price of $73.09.

Stock Performance

Full History
1D-2.75%
1W+2.38%
1M+0.55%
3M+22.18%
YTD+10.09%
1Y+341.10%
5Y-9.87%

About Arrowhead Pharmaceuticals, Inc.

CEOChristopher R. Anzalone
IPO DateDec 16, 1993
Employees609
CountryUS

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therap…

what is arrowhead pharmaceuticals, inc. · arwr stock overview · arrowhead pharmaceuticals, inc. company profile · who is arrowhead pharmaceuticals, inc. ceo · arwr NASDAQ · arrowhead pharmaceuticals, inc. headquarters · arrowhead pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Arrowhead Pharmaceuticals, Inc. (ARWR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 16, 1993. As of the latest trading session, ARWR stock price is $73.09, with a market capitalization of $10.3B. The stock has returned +341.10% over the past 12 months and +10.09% year-to-date.

According to 20 Wall Street analysts, the consensus rating for Arrowhead Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $83.56. In fiscal year 2025, Arrowhead Pharmaceuticals, Inc. reported revenue of $829.4M and net income of -$1.6M. For detailed data — including Arrowhead Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Arrowhead Pharmaceuticals, Inc. (ARWR) stock price is $73.09. The stock is traded on NASDAQ under the ticker symbol ARWR. The 52-week range is $14.30 – $82.26.

ARWR stock priceARWR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice